Staar Surgical (Nasdaq:STAA) announced today that it appointed a new chief operating officer and chief clinical, regulatory and medical affairs officer. The Lake Forest, California-based implantable eye lens maker named Warren Foust as its new COO. Magda Michna takes over as chief clinical, regulatory and medical affairs officer. Staar’s global head of regulatory affairs, Denise […]
Optical/Ophthalmic
RxSight stock rises on Street-beating Q4
RxSight (Nasdaq:RXST) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. Shares of RXST rose 1.1% at $15.85 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.4%. The Aliso Viejo, California-based ophthalmic medical device maker […]
Precision Lens faces $48M verdict in kickbacks case
A federal jury in Minnesota has handed down a $48 million verdict in a kickbacks case involving cataract surgery lens distributor Precision Lens. The jury yesterday found that Cameron-Ehlen Group, which does business as Bloomington, Minnesota–based Precision Lens, and its owner Paul Ehlen violated the False Claims Act and Anti-Kickback Statute. Federal prosecutors claimed the […]
Alcon says sales could grow up to 8% this year
Alcon (SIX/NYSE:ALC) reported fourth-quarter revenues that beat the consensus of Wall Street analysts, with earnings in-line with expectations. The Geneva-based eye care tech company yesterday evening also released 2023 guidance that was ahead of The Street’s consensus. However, Alcon’s actual Q4 results showed slowing sales growth as the company swung to a loss. Alcon lost […]
Glaukos submits FDA New Drug Application for iDose TR drug-eluting implant
Glaukos (NYSE:GKOS) announced today that it submitted a New Drug Application (NDA) to the FDA for its iDose TR implant. Aliso Viejo, California-based Glaukos designed iDose TR as a micro-invasive intraocular implant. It continuously delivers therapeutic levels of a proprietary formulation of travoprost from within the eye over extended periods of time. Once all travoprost […]
Glaukos beats The Street in Q4
Glaukos (NYSE:GKOS) shares took a hit today despite fourth-quarter results that topped the consensus forecast. Shares of GKOS dipped 7% at $46.90 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 8.1%. The Aliso Viejo, California-based ophthalmic implant maker posted losses of […]
RightEye receives FDA warning that its product is a medical device
An FDA inspection claims that eye-tracking biomarker developer RightEye misbranded and adulterated its medical device. The agency wrote in a letter, dated Dec. 20, 2022, that it inspected RightEye’s Bethesda, Maryland facility over 10 days in June and July 2022. In this inspection, it declared the RightEye Vision System a Class II Nystagmograph medical device. […]
Bausch + Lomb names Brent Saunders as new CEO
Bausch + Lomb (NYSE:BLCO) announced today that it appointed Brent Saunders as CEO and chair of its board of directors. Saunders succeeds Joseph C. Papa in the role, effective March 6, 2023. Papa announced his intention to step down in July 2022. When Papa announced his plans to depart, the optical and ophthalmic device maker […]
Alcon to pay $199M to J&J to settle patent dispute
Alcon (SIX/NYSE: ALC) recently announced that it has settled a patent dispute with J&J Surgical Vision. The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx […]
Bausch + Lomb buys AcuFocus and its intraocular lens tech
Bausch + Lomb (NYSE:BLCO) announced that its affiliate acquired AcuFocus, a privately held maker of ophthalmic medical devices. The deal remains pursuant to a merger transaction with the parent company of AcuFocus. Neither company disclosed the financial terms of the transaction. AcuFocus develops small aperture intraocular technology. Its portfolio includes the IC-8 Apthera intraocular lens […]
Corza Medical expands leadership team with three new executives
Corza Medical today announced it appointed three new executives to its leadership team. Westwood, Massachusetts-based Corza Medical appointed Thierry Leclercq as senior VP of biosurgery, James Getty as VP of technology and Jack Simmons as senior VP of ophthalmology. “Corza Medical is intensely focused on making every customer interaction remarkable, earning client’s trust through our […]